Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Mesothelioma × Photochemotherapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1

Conditions

Keratosis, Actinic 21 Carcinoma, Basal Cell 8 Carcinoma, Non-Small-Cell Lung 7 Squamous Cell Carcinoma of Head and Neck 6 Cholangiocarcinoma 6 Skin Neoplasms 4 Pancreatic Neoplasms 3 Mesothelioma, Malignant 3 Lung Neoplasms 3 Liver Neoplasms 3 Leukoplakia, Oral 3 Bile Duct Neoplasms 3 Warts 2 Tongue Neoplasms 2 Prostatic Neoplasms 2 Pleural Diseases 2 Neoplasms 2 Neoplasm Metastasis 2 Mycosis Fungoides 2 Glioblastoma 2 Esophageal Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Squamous Cell 2 Bowen's Disease 2 Basal Cell Nevus Syndrome 2 Barrett Esophagus 2 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1

Interventions

Pemetrexed 35 Cisplatin 30 pembrolizumab 19 Nivolumab 15 Carboplatin 15 Ipilimumab 11 Gemcitabine 9 Cyclophosphamide 7 durvalumab 6 fludarabine 5 Bevacizumab 5 Radiotherapy, Intensity-Modulated 4 Dexamethasone 4 tremelimumab 3 tazemetostat 3 olaparib 3 niraparib 3 anetumab ravtansine 3 Vinorelbine 3 Paclitaxel 3 LMB-100 3 Imatinib Mesylate 3 Fluorouracil 3 Cerebral Decortication 3 Blood Specimen Collection 3 sargramostim 2 fludarabine phosphate 2 defactinib 2 budigalimab 2 belinostat 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02662504 2026-02-05

MesoPDT

University Hospital, Lille

Phase 2 Completed

Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡